APOA1 and Alzheimer disease: Using the 2019 IGAP AD PRS metric, the strongest associations were between AD genetic risk and several LDL-related metabolites in addition to ApoB, ApoB to ApoA1 ratio, and IDL concentration (See supplementary datasheet 2).